Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 101 Leukemia 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 95 Myelodysplastic Syndromes 83 Leukemia, Lymphocytic, Chronic, B-Cell 78 Lymphoma, Non-Hodgkin 76 Multiple Myeloma 67 Hodgkin Disease 67 Lymphoma, Mantle-Cell 63 Lymphoma 62 Lymphoma, Large B-Cell, Diffuse 60 Lymphoma, Follicular 59 Leukemia, Myeloid, Chronic-Phase 57 Lymphoma, B-Cell, Marginal Zone 53 Burkitt Lymphoma 53 Lymphoma, Large-Cell, Immunoblastic 49 Leukemia, Myeloid, Accelerated Phase 48 Congenital Abnormalities 48 Myeloproliferative Disorders 46 Leukemia, Myelomonocytic, Chronic 43 Anemia, Refractory, with Excess of Blasts 41 Graft vs Host Disease 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Blast Crisis 33 Recurrence 32 Dendritic Cell Sarcoma, Interdigitating 32 Primary Myelofibrosis 27 Lymphoma, T-Cell, Cutaneous 27 Neoplasms, Plasma Cell 26 Waldenstrom Macroglobulinemia 25

Interventions

rozanolixizumab 11 efgartigimod alfa 10 zilucoplan 8 Prednisone 8 Cyclophosphamide 8 ravulizumab 7 Rituximab 7 Pyridostigmine Bromide 7 telitacicept 6 fludarabine 6 Tacrolimus 6 Mycophenolic Acid 6 eculizumab 5 Immunoglobulins, Intravenous 5 Hizentra 4 Azathioprine 4 Steroids 3 HBM9161 3 Data Collection 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Exercise 2 Diagnostic Self Evaluation 2 Blood Specimen Collection 2 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Cyclosporine × Clear all

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡